SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (783)12/17/2001 9:57:43 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 2243
 
I attribute much of DNA's success to Goeddel, and I respect those who I know personally and who are ass'd with the company.

IMO, the deals are complementary. I also believe that they have the capacity to manage and integrate the new business units.

I'm most attracted to T507 and the oral-active molecules for chronic inflammation.



To: quidditch who wrote (783)1/4/2002 10:01:16 PM
From: scaram(o)uche  Respond to of 2243
 
Wo! Was looking for a "Goeddel" post, and therefore found and read my response to you. I don't even know if there is a T507. I presume that you know that I meant T607, the amide prodrug for T67.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News